In yesterday’s Wall Street session, Senseonics Holdings Inc. (AMEX:SENS) shares traded at $0.57, down -8.62% from the previous session.
5 analysts cover Senseonics Holdings Inc. (AMEX:SENS), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $2.50 and a low of $0.50, we find $2.00. Given the previous closing price of $0.62, this indicates a potential upside of 222.58 percent. SENS stock price is now -21.74% away from the 50-day moving average and -32.76% away from the 200-day moving average. The market capitalization of the company currently stands at $286.92M.
The stock has received a hold rating from 1 analysts and a buy rating from 2. Brokers who have rated the stock have averaged $1.67 as their price target over the next twelve months.
With the price target of $0.50, Jefferies recently initiated with Underperform rating for Senseonics Holdings Inc. (AMEX: SENS).
In other news, Larkin Sharon, Director sold 30,889 shares of the company’s stock on Sep 07. The stock was sold for $18,842 at an average price of $0.61. Upon completion of the transaction, the Director now directly owns 292,476 shares in the company, valued at $0.17 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 30, Director ROEDER DOUGLAS A bought 300,000 shares of the business’s stock. A total of $162,000 was incurred on buying the stock at an average price of $0.54. This leaves the insider owning 807,988 shares of the company worth $0.46 million. Insiders disposed of 2,237,377 shares of company stock worth roughly $1.28 million over the past 1 year. A total of 1.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SENS stock. A new stake in Senseonics Holdings Inc. shares was purchased by RENAISSANCE TECHNOLOGIES LLC during the first quarter worth $1,014,000. TFG ASSET MANAGEMENT GP LTD invested $983,000 in shares of SENS during the first quarter. In the first quarter, CUBIST SYSTEMATIC STRATEGIES, LLC acquired a new stake in Senseonics Holdings Inc. valued at approximately $776,000. GMT CAPITAL CORP acquired a new stake in SENS for approximately $416,000. QUBE RESEARCH & TECHNOLOGIES LTD purchased a new stake in SENS valued at around $399,000 in the second quarter. In total, there are 213 active investors with 27.50% ownership of the company’s stock.
On Wednesday morning Senseonics Holdings Inc. (AMEX: SENS) stock kicked off with the opening price of $0.6204. During the past 12 months, Senseonics Holdings Inc. has had a low of $0.50 and a high of $1.63. As of last week, the company has a debt-to-equity ratio of 0.74, a current ratio of 8.70, and a quick ratio of 8.10. The fifty day moving average price for SENS is $0.7239 and a two-hundred day moving average price translates $0.8448 for the stock.
The latest earnings results from Senseonics Holdings Inc. (AMEX: SENS) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.04, inline with analysts’ expectations of -$0.04. This compares to $0.17 EPS in the same period last year. The company reported revenue of $4.13 million for the quarter, compared to $3.71 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.09 percent. For the current quarter, analysts expect SENS to generate $5.61M in revenue.
Senseonics Holdings Inc.(SENS) Company Profile
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
